REPATH LAUNCH
15 September 2026
therapy-and-psychology
REPATH, Genspect's re-psychopathologisation campaign, calls for restoring a psychiatric framework around gender dysphoria — one that distinguishes transgender ideation from gender non-conformity and replaces automatic affirmation with thorough differential diagnosis. Stella O'Malley and Mia Hughes mark the launch by examining what clinical neutrality looks like, why institutions abandoned it so quickly, and why reclaiming it is both a medical and a cultural necessity.
The launch of REPATH marks a formal, organised challenge to one of the most consequential shifts in recent psychiatric history. Genspect's re-psychopathologisation campaign calls for something that, a generation ago, would have been unremarkable: that a person presenting with distress about their gender should receive thorough differential diagnosis and psychological care before any other intervention. The fact that this now requires a dedicated campaign tells you a great deal about how far clinical norms have moved — and how quickly. At the heart of REPATH is a distinction that much of the current debate obscures. The campaign does not call for pathologising gender non-conformity. A boy who prefers dresses, a girl who despises femininity — these are not disorders, and REPATH does not treat them as such. What it does insist on is that transgender ideation — the conviction that one is, or must become, the opposite sex — deserves serious psychiatric attention rather than administrative validation. That distinction, simple as it sounds, is the fault line running through contemporary gender medicine. Stella O'Malley and Mia Hughes explore how automatic affirmation became the default and what has been lost as a result. When a presenting complaint is affirmed rather than explored, the underlying causes remain unexamined. Anxiety, trauma, autism, depression, sexual orientation confusion, social contagion — all of these have been documented among young people seeking gender care, yet the affirmation model has functioned as a framework that closes down clinical inquiry rather than opening it. Differential diagnosis is not a barrier to care; it is the foundation of responsible medicine. The institutional story here is one of capture. Psychiatric and psychological bodies across the Western world moved, in a relatively short period, from clinical caution to ideological commitment. REPATH is in part a recognition that this shift did not happen by accident. It happened through revised diagnostic manuals, through sustained lobbying, and through the redefinition of watchful clinical neutrality as harm. Reclaiming that space requires not just individual practitioners willing to push back, but organised, visible campaigns that name what has changed and why. What makes the REPATH launch significant beyond the clinical domain is what it signals about the broader contest over gender orthodoxy. The campaign speaks the language of medicine and evidence, not politics. Its demand — that psychiatric understanding be restored before any pathway is offered — is difficult to dismiss as ideologically motivated precisely because it is grounded in the same evidential framework that medicine claims to follow. It forces the debate back onto terrain where rigour has weight. O'Malley and Hughes capture the energy of a moment when that terrain is being actively reclaimed.
